Skip to main content

Living in Highly Segregated Neighborhood Tied to Lower Life Expectancy

Medically reviewed by Drugs.com.

By Lori Solomon HealthDay Reporter

FRIDAY, July 14, 2023 -- Residing in a highly segregated neighborhood is associated with significantly lower life expectancy, according to a research letter published online July 14 in JAMA Health Forum.

Sadiya S. Khan, M.D., from the Northwestern University Feinberg School of Medicine in Chicago, and colleagues evaluated the association between neighborhood-level residential segregation and life expectancy using 2010 to 2015 data from the U.S. Small-Area Life Expectancy Estimates Project and sociodemographic factors self-reported from the American Community Survey (2010 to 2014).

The researchers found that in the 63,694 included census tracts, mean life expectancy was 78.3 years and was significantly lower in neighborhoods with higher racial segregation (high, 75.1 years; medium, 77.3 years; and low, 79.3 years). A higher mean percentage of residents lacked a college education in highly segregated versus low segregated neighborhoods (81 versus 69 percent). Results were similar for residents living below the federal poverty level (24 versus 11 percent) and for those who were unemployed (16 versus 8 percent). There was significant mediation of the association between racial segregation and life expectancy by education (β −0.201), poverty (β −0.270), and unemployment (β −0.052), but the association remained independently significant.

"These findings contribute to growing evidence of place-based disadvantage due to residential segregation that limit access to health-promoting factors (e.g., education, employment, wealth) and may enhance exposure to health-harming factors (e.g., air pollution) in contemporary estimates of life expectancy," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours

WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...

Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million

TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...

Patient–Primary Care Provider Language Concordance Tied to Better Outcomes

TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.